EP0831824A4 - ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS - Google Patents
ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTSInfo
- Publication number
- EP0831824A4 EP0831824A4 EP96919056A EP96919056A EP0831824A4 EP 0831824 A4 EP0831824 A4 EP 0831824A4 EP 96919056 A EP96919056 A EP 96919056A EP 96919056 A EP96919056 A EP 96919056A EP 0831824 A4 EP0831824 A4 EP 0831824A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- alpha
- receptor antagonists
- adrenergic receptor
- adrenergic
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US470164 | 1990-01-25 | ||
US47016495A | 1995-06-06 | 1995-06-06 | |
PCT/US1996/008672 WO1996039140A1 (en) | 1995-06-06 | 1996-06-04 | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0831824A1 EP0831824A1 (en) | 1998-04-01 |
EP0831824A4 true EP0831824A4 (en) | 2001-05-02 |
Family
ID=23866530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96919056A Withdrawn EP0831824A4 (en) | 1995-06-06 | 1996-06-04 | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0831824A4 (en) |
JP (1) | JP2001516330A (en) |
AU (1) | AU705661B2 (en) |
CA (1) | CA2221842A1 (en) |
WO (1) | WO1996039140A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2355263A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists |
GB2355457A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel spirotricyclic substituted azacycloalkane derivatives useful as alpha 1a adrenoceptor antagonists |
WO2004092179A1 (en) * | 2003-04-14 | 2004-10-28 | Nippon Soda Co. Ltd. | Spiro derivative, production process, and antioxidant |
ATE509023T1 (en) | 2005-07-19 | 2011-05-15 | Merck Sharp & Dohme | SPIROCHROMANONE DERIVATIVES AS ACETYL COENZYME A CARBOXYLASE INHIBITORS |
WO2007063385A2 (en) * | 2005-12-01 | 2007-06-07 | Pfizer Products Inc. | Spirocyclic amine histamine-3 receptor antagonists |
MX2009005604A (en) * | 2006-11-29 | 2009-06-08 | Pfizer Prod Inc | Spiroketone acetyl-coa carboxylase inhibitors. |
PE20081559A1 (en) | 2007-01-12 | 2008-11-20 | Merck & Co Inc | SPIROCHROMANONE DERIVATIVES SUBSTITUTED AS ACETYL COA CARBOXYLASE INHIBITORS |
WO2008088692A2 (en) * | 2007-01-12 | 2008-07-24 | Merck & Co., Inc. | Spirochromanon derivatives |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206240A (en) * | 1989-12-08 | 1993-04-27 | Merck & Co., Inc. | Nitrogen-containing spirocycles |
WO1994010989A1 (en) * | 1992-11-13 | 1994-05-26 | Synaptic Pharmaceutical Corporation | Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
WO1994018204A1 (en) * | 1993-02-12 | 1994-08-18 | Merck & Co., Inc. | Spiro (2h-1-benzopyran-2, 4' piperidine) class iii antiarrhythmics |
-
1996
- 1996-06-04 JP JP50118697A patent/JP2001516330A/en active Pending
- 1996-06-04 EP EP96919056A patent/EP0831824A4/en not_active Withdrawn
- 1996-06-04 CA CA002221842A patent/CA2221842A1/en not_active Abandoned
- 1996-06-04 AU AU61497/96A patent/AU705661B2/en not_active Ceased
- 1996-06-04 WO PCT/US1996/008672 patent/WO1996039140A1/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206240A (en) * | 1989-12-08 | 1993-04-27 | Merck & Co., Inc. | Nitrogen-containing spirocycles |
WO1994010989A1 (en) * | 1992-11-13 | 1994-05-26 | Synaptic Pharmaceutical Corporation | Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
WO1994018204A1 (en) * | 1993-02-12 | 1994-08-18 | Merck & Co., Inc. | Spiro (2h-1-benzopyran-2, 4' piperidine) class iii antiarrhythmics |
Non-Patent Citations (2)
Title |
---|
See also references of WO9639140A1 * |
YAMATO M ET AL: "SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP OF SPIRO UISOCHROMANPIPERIDINE ANALOGS FOR INHIBITION OF HISTAMINE RELEASE", CHEMICAL AND PHARMACEUTICAL BULLETIN,JP,PHARMACEUTICAL SOCIETY OF JAPAN. TOKYO, vol. 29, no. 12, 1 December 1981 (1981-12-01), pages 3494 - 3498, XP000651856, ISSN: 0009-2363 * |
Also Published As
Publication number | Publication date |
---|---|
CA2221842A1 (en) | 1996-12-12 |
WO1996039140A1 (en) | 1996-12-12 |
JP2001516330A (en) | 2001-09-25 |
AU6149796A (en) | 1996-12-24 |
EP0831824A1 (en) | 1998-04-01 |
AU705661B2 (en) | 1999-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0822814A4 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS | |
EP0998285A4 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS | |
EP0833637A4 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST | |
HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
HU9603525D0 (en) | Vironectin receptor antagonists | |
HUP0000467A3 (en) | Il-8 receptor antagonists | |
IL125030A0 (en) | Vitronectin receptor antagonists | |
HUP9900754A3 (en) | Vitronectin receptor antagonists | |
IL125034A0 (en) | Vitronectin receptor antagonists | |
GB9817910D0 (en) | CCR-3 receptor antagonists | |
EP0810994A4 (en) | Fibrinogen receptor antagonists | |
EP0831823A4 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS | |
EP0866705A4 (en) | Fibrinogen receptor antagonists | |
ZA963535B (en) | Adhesion receptor antagonists | |
EP0755392A4 (en) | Alpha1c adrenergic receptor antagonists | |
EP1019052A4 (en) | Alpha 1a adrenergic receptor antagonists | |
EP1023068A4 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS | |
EP0831824A4 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS | |
EP1014973A4 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS | |
HU9600333D0 (en) | Adhesive receptor antagonists | |
EP0853479A4 (en) | ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS | |
EP0773959A4 (en) | Adrenergic receptor | |
EP0812196A4 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS | |
AU5234899A (en) | Alpha 1a adrenergic receptor antagonists | |
AU7734496A (en) | Alpha 1a adrenergic receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980107 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010321 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20000703 |